Skip to Content
Merck
CN
  • MEK/ERK MAP kinase limits poly I:C-induced antiviral gene expression in RAW264.7 macrophages by reducing interferon-beta expression.

MEK/ERK MAP kinase limits poly I:C-induced antiviral gene expression in RAW264.7 macrophages by reducing interferon-beta expression.

FEBS letters (2021-10-01)
Shawn M Freed, Danielle S Baldi, Jason A Snow, Sierra R Athen, Zachary P Guinn, T Scott Pinkerton, Thomas M Petro, Tyler C Moore
ABSTRACT

Toll-like receptor 3 (TLR3) recognizes viral double-stranded RNA (or the synthetic dsRNA analog poly I:C) and induces a signal transduction pathway that results in activation of transcription factors that induce expression of antiviral genes including type I interferon (IFN-I). Secreted IFN-I positively feeds back to amplify antiviral gene expression. In this report, we study the role of MEK/ERK MAP kinase in modulating antiviral gene expression downstream of TLR3. We find MEK/ERK is a negative regulator of antiviral gene expression by limiting expression of IFN-β. However, MEK/ERK does not limit antiviral responses downstream of the type I interferon receptor. These findings provide insights into regulatory mechanisms of antiviral gene expression and reveal potential targets for modulating antiviral immunity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Interferon-β Protein, Recombinant mouse, Interferon-β Protein, Recombinant mouse.